Related Experiment Videos
[Congenital aplastic anemias]
Insights
Congenital aplastic anemias are rare but fatal pediatric blood disorders. This review details their characteristics, causes, and treatment, offering insights into prognosis for these pancytopenias.
Area of Science:
- Pediatric Hematology
- Genetics
- Oncology
Background:
- Congenital aplastic anemias are rare, often fatal pediatric conditions.
- These anemias manifest as pancytopenia, affecting red blood cells, white blood cells, and platelets.
- Despite pancytopenia, the term aplastic anemia is commonly used.
Abstract:
Congenital (constitutional) aplastic anemias in children are relatively rare compared to other diseases but as their outcome is nearly always fatal they are given full attention in pediatric-hematological literature. Although in many patients the number of white cells and thrombocytes as well as of red cells is diminished even in the first phase of the disease (or later in the course of the disease) so that these diseases are really pancytopenias, the term most frequently used to describe these clinical entities is aplastic anemia. The clinical and hematological characteristics of some aplastic anemias (Fanconi's anemia, Blackfan-Diamond's anemia, congenital dyserythropoietic anemia--type I, II, III and IV, etc.) are described. After considering the possible pathomechanisms which bring about aplastic anemia (pancytopenia), information is given about the method of treatment and prognostic prospects with reference to cases treated by the authors.